Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,316 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,316 Papers indexed
1,440 Papers AI scored
40,316 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40316 results
D
Rubinstein-Taybi syndrome with ganglioneuroblastoma: a case report and literature review.
PMID 40159473 Published: 2025-03-31 Ingested: 2026-08-02 12:04 AM BMC pediatrics
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Case report: Clinical and genetic features of pediatric choroidal melanoma.
PMID 40151649 Published: 2025-03-13 Ingested: 2026-08-02 12:04 AM Frontiers in medicine
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
IVCA in a Boy with Multilocular Renal Cyst as a Risk Factor for Deep Vein Thrombosis.
PMID 40146660 Published: 2025-03-25 Ingested: 2026-08-02 12:04 AM Journal of mother and child
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Utility of Bronchoalveolar Lavage in Immunocompromised Children: Is the Bronch Result in the Eye of the Beholder or Is It a Wash?
PMID 40127029 Published: 2025-03-12 Ingested: 2026-08-02 12:04 AM Journal of the Pediatric Infectious Diseases Society
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Lipoblastoma of the Scalp in a Pediatric Patient.
PMID 40125465 Published: 2025-03-21 Ingested: 2026-08-02 12:04 AM Plastic and reconstructive surgery. Global open
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Editorial: Global approaches to molecular diagnostics for pediatric cancer.
PMID 40115010 Published: 2025-03-06 Ingested: 2026-08-02 12:03 AM Frontiers in oncology
AI -
Standard 46.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 46.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

Previous
Page 3105 of 3360
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic